Real-time enrollment status for this colorectal cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05253651 |
| Recruiting Status | Recruiting |
| Condition | Colorectal Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 400 participants |
| Active Locations | 127 sites in the US |
| Sponsor | Seagen, a wholly owned subsidiary of Pfizer |
| Last Updated on CT.gov | December 17, 2025 (Dec 17, 2025) |
As of March 2, 2026: Clinical trial NCT05253651 is currently recruiting participants. This clinical trial study for colorectal cancer is actively seeking new participants at 127 locations across the United States. The study is sponsored by Seagen, a wholly owned subsidiary of Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05253651 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 127 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05253651 was last updated Dec 17, 2025 (December 17, 2025). HelloStudys verifies this status automatically.